Similarity is based on the correlation of the price action of the past 100 trading sessions.
The reference chart (CWBR) is shown first. Other charts are sorted by their correlation and the most similar chart is ranked highest.
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases.
It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
This website uses cookies. To learn more about cookies, please see our privacy policy .